HighMark Wealth Management’s Arena Pharmaceuticals Inc ARNA Stock Holding History

HighMark Wealth Management’s Portfolio ARNA Stock Details ARNA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q1	–	Sell	-250	Closed	-$23K	–	552
2021 Q4	$23K	Sell	250 -308	-55%	-$20.3K	0.01%	169
2021 Q3	$33K	Buy	558 +42	+8%	+$2.48K	0.02%	142
2021 Q2	$35K	Buy	516 +314	+155%	+$20.5K	0.03%	143
2021 Q1	$14K	Sell	202 -58	-22%	-$4.46K	0.01%	199
2020 Q4	$20K	Sell	260 -708	-73%	-$53.1K	0.02%	164
2020 Q3	$72K	Buy	968 +867	+858%	+$57.8K	0.06%	84
2020 Q2	$6K	Buy	+101	New	+$5.56K	0.01%	301

HighMark Wealth Management's ARNA Position: Q1 2022 in Review

HighMark Wealth Management sold out of Arena Pharmaceuticals Inc (ARNA) in Q1 2022, closing a stake of 250 shares — an estimated $23K sold.

HighMark Wealth Management first reported a position in ARNA in Q2 2020 and held it in 7 quarters. The position peaked at $72K in Q3 2020. 1 fund tracked by Wall St. Rank holds ARNA as of Q1 2022.

HighMark Wealth Management reported no remaining Arena Pharmaceuticals Inc position as of Q1 2022 after selling out during the quarter.
HighMark Wealth Management sold 250 Arena Pharmaceuticals Inc shares in Q1 2022, an estimated $23K.
HighMark Wealth Management first reported a position in Arena Pharmaceuticals Inc in Q2 2020 and held it in 7 quarters.
HighMark Wealth Management's Arena Pharmaceuticals Inc position peaked at $72K in Q3 2020.
1 fund tracked by Wall St. Rank held Arena Pharmaceuticals Inc as of Q1 2022.

Based on HighMark Wealth Management's 13F filing for Q1 2022, filed 25 Apr 2022.